NZ211526A - Cyclosporin derivatives with d-acyloxy-alpha-amino acid residue at the 8-position and pharmaceutical compositions - Google Patents

Cyclosporin derivatives with d-acyloxy-alpha-amino acid residue at the 8-position and pharmaceutical compositions

Info

Publication number
NZ211526A
NZ211526A NZ211526A NZ21152685A NZ211526A NZ 211526 A NZ211526 A NZ 211526A NZ 211526 A NZ211526 A NZ 211526A NZ 21152685 A NZ21152685 A NZ 21152685A NZ 211526 A NZ211526 A NZ 211526A
Authority
NZ
New Zealand
Prior art keywords
acyloxy
alpha
amino acid
pharmaceutical compositions
acid residue
Prior art date
Application number
NZ211526A
Other languages
English (en)
Inventor
R Wenger
R P Traber
H Kobel
H Hofmann
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848407618A external-priority patent/GB8407618D0/en
Priority claimed from GB848411922A external-priority patent/GB8411922D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ211526A publication Critical patent/NZ211526A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NZ211526A 1984-03-23 1985-03-21 Cyclosporin derivatives with d-acyloxy-alpha-amino acid residue at the 8-position and pharmaceutical compositions NZ211526A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848407618A GB8407618D0 (en) 1984-03-23 1984-03-23 Organic compounds
GB848411922A GB8411922D0 (en) 1984-05-10 1984-05-10 Organic compounds

Publications (1)

Publication Number Publication Date
NZ211526A true NZ211526A (en) 1988-08-30

Family

ID=26287502

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ211526A NZ211526A (en) 1984-03-23 1985-03-21 Cyclosporin derivatives with d-acyloxy-alpha-amino acid residue at the 8-position and pharmaceutical compositions

Country Status (24)

Country Link
US (1) US4639434A (en:Method)
JP (1) JPH08838B2 (en:Method)
AT (1) AT388737B (en:Method)
BE (1) BE901980A (en:Method)
CA (1) CA1247546A (en:Method)
CH (1) CH667274A5 (en:Method)
CS (1) CS249542B2 (en:Method)
DE (1) DE3509809A1 (en:Method)
DK (1) DK128285A (en:Method)
ES (1) ES8702926A1 (en:Method)
FI (1) FI851120A7 (en:Method)
FR (1) FR2561651B1 (en:Method)
GB (1) GB2155936B (en:Method)
GR (1) GR850716B (en:Method)
HU (1) HU200786B (en:Method)
IL (1) IL74681A (en:Method)
IT (1) IT1199962B (en:Method)
LU (1) LU85819A1 (en:Method)
NL (1) NL8500828A (en:Method)
NO (1) NO851160L (en:Method)
NZ (1) NZ211526A (en:Method)
PH (2) PH21868A (en:Method)
PT (1) PT80149B (en:Method)
SE (1) SE461334B (en:Method)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3587505T2 (de) 1984-10-04 1994-01-05 Sandoz Ag Monoklonale antikörper gegen zyklosporine.
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
ATE95193T1 (de) * 1987-06-17 1993-10-15 Sandoz Ag Cyclosporine und deren benutzung als arzneimittel.
EP0373260B1 (en) * 1987-06-22 1994-03-09 Merck & Co. Inc. Cyclosporin derivatives with modified "8-amino acid"
US5227467A (en) * 1987-08-03 1993-07-13 Merck & Co., Inc. Immunosuppressive fluorinated cyclosporin analogs
KR920003601B1 (ko) * 1987-09-03 1992-05-04 유니버시티 어브 죠지아 리서취 화운데이션 인코포레이티드 점안 싸이클로스포린(cyclosporin)의 조성물
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
US5089390A (en) * 1987-09-04 1992-02-18 Syntex (U.S.A.) Inc. 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives
US5236899A (en) * 1987-11-16 1993-08-17 Merck & Co., Inc. 6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance
US4914188A (en) * 1987-11-16 1990-04-03 Merck & Co., Inc. Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
CH679119A5 (en:Method) * 1988-05-13 1991-12-31 Sandoz Ag
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US5122511A (en) * 1990-02-27 1992-06-16 Merck & Co., Inc. Immunosuppressive cyclosporin analogs with modified amino acids at position-8
US5202310A (en) * 1990-06-06 1993-04-13 Levy Gary A Cyclosporine metabolites
DE69124459T3 (de) * 1990-11-02 2001-05-31 Novartis Ag, Basel Zyklosporine
ES2091301T3 (es) 1990-11-20 1996-11-01 Behringwerke Ag Inmunoensayo de ciclosporina.
US5747330A (en) * 1996-06-05 1998-05-05 Poli Industria Chimica Antibiotic producing microbe
RU2170741C2 (ru) * 1996-08-16 2001-07-20 Новартис Аг Способ получения циклоспорина
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
EP0991660B8 (en) 1997-10-08 2006-04-05 Isotechnika,Inc. DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS
US5990274A (en) 1997-11-25 1999-11-23 Dade Behring Inc. Cyclosporine derivatives and uses thereof
US7449544B2 (en) * 1999-11-30 2008-11-11 Cyclacel Limited p21 peptides
EP1436321B9 (en) 2001-10-19 2008-11-12 Isotechnika Inc. Synthesis of cyclosporin analogs
AU2002333098B2 (en) * 2001-10-19 2006-03-16 Isotechnika Pharma Inc. Novel cyclosporin analog microemulsion preconcentrates
JP2006524232A (ja) * 2003-03-17 2006-10-26 アルバニー モレキュラー リサーチ インコーポレーティッド 新規サイクロスポリン
US7378391B2 (en) * 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
EP1804823A4 (en) * 2004-09-29 2010-06-09 Amr Technology Inc NEW CYCLOSPORIN ANALOGUE AND ITS PHARMACEUTICAL APPLICATIONS
JP2008515886A (ja) * 2004-10-06 2008-05-15 エーエムアール テクノロジー インコーポレイテッド シクロスポリンアルキンおよびそれらの医用薬剤としての有用性
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
WO2008069917A2 (en) 2006-11-20 2008-06-12 Scynexis, Inc. Novel cyclic peptides
KR102011339B1 (ko) 2010-12-15 2019-08-16 콘트라빌 파마슈티컬스, 인코퍼레이티드 아미노산 1 및 3에서 변형된 사이클로스포린 유사체 분자
WO2012125569A2 (en) 2011-03-11 2012-09-20 Beth Israel Deaconess Medical Center, Inc. Anti-cd40 antibodies and uses thereof
CN104877013B (zh) * 2015-06-03 2018-04-20 兰州大学 环孢菌素t及其制备方法和应用
PT3307322T (pt) 2015-09-04 2021-04-23 Primatope Therapeutics Inc Anticorpos anti-cp40 humanizados e as suas utilizações referência cruzada relativa às aplicações associadas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4384996A (en) * 1981-01-09 1983-05-24 Sandoz Ltd. Novel cyclosporins
JPS57140753A (en) * 1981-01-09 1982-08-31 Sandoz Ag Novel cyclosporine

Also Published As

Publication number Publication date
IT8547852A1 (it) 1986-09-22
FR2561651A1 (fr) 1985-09-27
US4639434A (en) 1987-01-27
FI851120A0 (fi) 1985-03-20
ES8702926A1 (es) 1987-01-16
GB8507270D0 (en) 1985-04-24
SE8501392L (sv) 1985-09-24
IL74681A (en) 1989-09-10
GR850716B (en:Method) 1985-07-19
PT80149B (en) 1987-03-23
ES541465A0 (es) 1987-01-16
ATA86385A (de) 1989-01-15
CA1247546A (en) 1988-12-28
DE3509809A1 (de) 1986-01-09
NO851160L (no) 1985-09-24
FI851120L (fi) 1985-09-24
FI851120A7 (fi) 1985-09-24
PT80149A (en) 1985-04-01
SE461334B (sv) 1990-02-05
PH23357A (en) 1989-07-14
IL74681A0 (en) 1985-06-30
CS249542B2 (en) 1987-03-12
FR2561651B1 (fr) 1990-03-09
LU85819A1 (fr) 1985-12-12
PH21868A (en) 1988-03-25
AT388737B (de) 1989-08-25
CH667274A5 (de) 1988-09-30
IT1199962B (it) 1989-01-05
SE8501392D0 (sv) 1985-03-21
IT8547852A0 (it) 1985-03-22
NL8500828A (nl) 1985-10-16
DK128285D0 (da) 1985-03-21
HU200786B (en) 1990-08-28
HUT38370A (en) 1986-05-28
JPS60215700A (ja) 1985-10-29
DK128285A (da) 1985-09-24
BE901980A (fr) 1985-09-23
GB2155936B (en) 1987-09-16
GB2155936A (en) 1985-10-02
JPH08838B2 (ja) 1996-01-10

Similar Documents

Publication Publication Date Title
NZ211526A (en) Cyclosporin derivatives with d-acyloxy-alpha-amino acid residue at the 8-position and pharmaceutical compositions
NZ212415A (en) 2-benzimidazolyl 2-pyridylmethylsulphide derivatives and pharmaceutical compositions
NZ211145A (en) 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
PH22014A (en) Heterocyclic derivatives and pharmaceutical compositions containing the same
IL76591A0 (en) Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
NZ212005A (en) Pyrrolobenzimidazoles and pharmaceutical compositions
NZ213528A (en) Purine derivatives and pharmaceutical compositions
GB8403359D0 (en) Pharmaceutical compositions
GB8814598D0 (en) New cyclosporin derivatives with modified"8-amino acid"
NZ212099A (en) Substituted arylhydroxamates and pharmaceutical compositions
NZ211031A (en) 6-substituted-4-dialkylaminotetrahindole derivatives and pharmaceutical compositions
GB2165451B (en) Pharmaceutical compositions
GB8410290D0 (en) Pharmaceutical compositions
PH21540A (en) Cholecalciferol derivatives and pharmaceutical compositions containing the same
GB8410289D0 (en) Pharmaceutical compositions
GB8403360D0 (en) Pharmaceutical compositions
NZ210818A (en) 8-alpha-acylaminoergoline derivatives and pharmaceutical compositions
NZ212953A (en) 3-acyl-1-aminoalkyl-1h-indoles and pharmaceutical compositions thereof
GB8409961D0 (en) Pharmaceutical compositions
NZ213581A (en) Carboxyalkyldipeptides and pharmaceutical compositions
PH21779A (en) Sulfonomidines and pharmaceutical compositions containing the same
NZ218614A (en) 16,17-butylidenedioxy-6,9-difluoro-11-hydroxy-3, 20-dioxopregna-1,4-diene-21-oic acid esters and pharmaceutical compositions
NZ220099A (en) Benzothiazinone derivatives and pharmaceutical compositions
NZ212946A (en) Quinoline derivatives and pharmaceutical compositions
NZ213394A (en) Penicillin derivatives and pharmaceutical compositions